Cancer Therapy & Oncology International Journal最新文献

筛选
英文 中文
Free Radical Scavenging and Cytotoxic Activities of Substituted Pyrimidines 取代嘧啶的自由基清除和细胞毒活性
Cancer Therapy & Oncology International Journal Pub Date : 2020-03-06 DOI: 10.19080/ctoij.2020.16.555940
Qurat-ul-ain, S. Hussain, M. I. Coudhary, K. Khan
{"title":"Free Radical Scavenging and Cytotoxic Activities of Substituted Pyrimidines","authors":"Qurat-ul-ain, S. Hussain, M. I. Coudhary, K. Khan","doi":"10.19080/ctoij.2020.16.555940","DOIUrl":"https://doi.org/10.19080/ctoij.2020.16.555940","url":null,"abstract":"A library of substituted pyrimidines was synthesized and evaluated for free radical scavenging, and in vitro cytotoxic activity in 3T3 cells. All compounds showed good free radical scavenging activity with IC50 values in the range of 42.9 + 0.31 to 438.3 3.3 {mu}M as compared to the standard butylated hydroxytoluene having IC50 value of 128.83 2. 1 {mu}M. The structure activity-relationship was also established. Selected analogues 1, 2, 3, 5, 6, 7, 8, 9, 10, 12, 13, 15, 19, 20, 21, 24, 25, 26 and 28 were tested for cytotoxicity in mouse fibroblast 3T3 cell line using MTT assay, and most of the analogues showed cytotoxicity. This study has identified a number of cytotoxic novel substituted pyrimidines having free radical scavenging activities that can be used as inhibitory compounds for those cancer cells whose growth is mediated by reactive oxygen species.","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88517669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Unusual presentations of Glioblastoma Posterior Fossa and spinal cord: Cases Presentations and Review of Literature 后窝及脊髓胶质母细胞瘤的异常表现:病例、报告及文献回顾
Cancer Therapy & Oncology International Journal Pub Date : 2020-03-06 DOI: 10.19080/CTOIJ.2020.15.555925
R. Tellez
{"title":"Unusual presentations of Glioblastoma Posterior Fossa and spinal cord: Cases Presentations and Review of Literature","authors":"R. Tellez","doi":"10.19080/CTOIJ.2020.15.555925","DOIUrl":"https://doi.org/10.19080/CTOIJ.2020.15.555925","url":null,"abstract":"In general, Glioblastomas multiforme frequently occurs in supratentorial region but in less than 4% occur in the posterior fossa predominantly in the cerebellum, and spinal cords tumors represents 6% to 8% of all central nervous system tumors and spinal cord glioblastomas occur only in 1.5% of all spinal cords tumors. We presents two cases a male whit posterior fossa glioblastoma and a girl with spinal cord glioblastoma in both cases, MRI is the study of choice with high sensitivity and specificity for diagnosis, after that they underwent biopsy and the results of pathology described GBM in both cases. The treatment of election is radiotherapy plus chemotherapy and surge if is possible, the prognosis is poor even with treatment, thats is why we need to identify new therapeutic strategies; We currently believe","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89558706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stage 3 Prostate Cancer Treated with a Plant-Based Diet – A Case Report 植物性饮食治疗3期前列腺癌1例报告
Cancer Therapy & Oncology International Journal Pub Date : 2020-02-20 DOI: 10.19080/CTOIJ.2020.15.555922
A. Strombom
{"title":"Stage 3 Prostate Cancer Treated with a Plant-Based Diet – A Case Report","authors":"A. Strombom","doi":"10.19080/CTOIJ.2020.15.555922","DOIUrl":"https://doi.org/10.19080/CTOIJ.2020.15.555922","url":null,"abstract":"Treatment of early stage prostate cancer (with a Gleason score less than seven) with a plant-based diet has been studied, and efficacy noted even after 5 years [1]. However, this is a case of a patient with Stage 3 prostate cancer, who chose to follow a plantbased diet after his diagnosis, and is still alive today, 32 years later, despite being given only a 10% chance of 3 year survival. While this case is anecdotal, and a plant-based diet was combined with standard treatment, it joins a growing body of evidence that prostate cancer is responsive to treatment with a plant-based diet. The patient’s longevity may also partially be the result of a plant-based diet preventing and treating common comorbidities such coronary artery disease [2], Type 2 diabetes [3], and renal failure [4].","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"94 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74875185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glutathione S-transferase Isoenzymes in Lung Carcinoma Patients receiving Platinum-based Chemotherapy and Effects of Ethyl Alcohol and Smoking on Treatment Response 肺癌铂类化疗患者谷胱甘肽s -转移酶同工酶及酒精和吸烟对治疗反应的影响
Cancer Therapy & Oncology International Journal Pub Date : 2020-02-18 DOI: 10.19080/CTOIJ.2020.15.555920
C. S. Kunak
{"title":"Glutathione S-transferase Isoenzymes in Lung Carcinoma Patients receiving Platinum-based Chemotherapy and Effects of Ethyl Alcohol and Smoking on Treatment Response","authors":"C. S. Kunak","doi":"10.19080/CTOIJ.2020.15.555920","DOIUrl":"https://doi.org/10.19080/CTOIJ.2020.15.555920","url":null,"abstract":"Mostly observed in men, lung carcinoma, mostly observed in men, is one of the most frequent cancer types in Turkey and in the world. About two thirds of the lung carcinoma patients have inoperable lesions. 113 primary lung cancer patients who were receiving platinum based treatment at Chest Diseases and Chest Surgery Center of Ankara Atatürk Hospital were enrolled for the study. It was identified that 49 (43%) patients had GSTM1 gene deletion out of a group of 113. It was identified that 42 (%), 34 (39%) and 10 (12%) patients had 105 (wild type) genotype, İ le 105 /Val 105 (heterozygote) genotype and Val 105 /Val 105 (homozygote mutant) genotype, respectively out of a group of 113. GSTP1 is the most strongly expressed isoenzyme in the human lung. In this study, the responses to cisplatine based chemotherapy of homozygous and heterozygous patients with GSTP1 exon5 variant allele were observed to be similar to the responses of the patients carrying wild type genotype. it is displayed that wild type genes have positive effect on the response to treatment. This result yields that it is important to evaluate the effect of combination of GST genotype, alcohol ingestion amount, smoking frequency on the response to treatment","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72735034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic Therapy for Male Breast Cancer 男性乳腺癌的全身治疗
Cancer Therapy & Oncology International Journal Pub Date : 2020-02-18 DOI: 10.19080/CTOIJ.2020.15.555921
A. Yousef
{"title":"Systemic Therapy for Male Breast Cancer","authors":"A. Yousef","doi":"10.19080/CTOIJ.2020.15.555921","DOIUrl":"https://doi.org/10.19080/CTOIJ.2020.15.555921","url":null,"abstract":"Male breast cancer is a rare malignancy accounting for < 1% of all cancers in men and < 1% of all breast cancers. Most of the cases are advanced stage ductal invasive carcinomas and express hormone receptors in the great majority and are less likely to over-express HER2-neu. Treatment includes locoregional methods such as surgery and radiotherapy, and systemic treatment mainly with hormonal therapy and, to a lesser extent, trastuzumab and chemotherapy as second lines. Nonetheless, the optimal treatment for male breast cancer is not known due to lack of prospective randomized trials. In this review systemic therapy for male breast cancer is discussed in the neoadjuvant and adjuvant settings, with insight into the treatment of advanced disease.","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75051509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Target Volume Definition for Stereotactic Radiosurgery (SRS) Of Cerebral Cavernous Malformations (CCMS) 脑海绵状血管瘤(CCMS)立体定向放射外科(SRS)靶体积定义
Cancer Therapy & Oncology International Journal Pub Date : 2020-01-31 DOI: 10.19080/CTOIJ.2020.15.555917
O. Sager
{"title":"Target Volume Definition for Stereotactic Radiosurgery (SRS) Of Cerebral Cavernous Malformations (CCMS)","authors":"O. Sager","doi":"10.19080/CTOIJ.2020.15.555917","DOIUrl":"https://doi.org/10.19080/CTOIJ.2020.15.555917","url":null,"abstract":"Objective: Cerebral cavernous malformations (CCMs) are composed of abnormal hyalinized capillary clusters typically surrounded by deposits of hemosiderin. These vascular abnormalities of the brain may be asymptomatic, however, a plethora of symptoms may occur in some of the affected patients including seizures, hemorrhages, and neurological deficits. Stereotactic radiosurgery (SRS) has been utilized as a noninvasive modality of management for selected patients with high risk CCMs located at eloquent brain regions typically not amenable to surgical removal. In this study, we assessed incorporation of multimodality imaging into target volume definition of CCM radiosurgery. Materials and methods: Twenty-three patients treated with SRS for CCM at our institution were included. Target definition with CT only and by incorporation of CT-MR fusion was comparatively evaluated. Results: Twenty-three patients receiving SRS for CCMs at our institution were evaluated for target volume determination using CT-only imaging and CT-MR fusion based imaging. Ground truth target volume defined by treating physicians after comprehensive assessment and consensus was identical to target definition using CT-MR fusion based imaging in the majority of patients. Conclusion: MRI may be utilized for improving the definition of SRS target for CCM management.","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77131129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
Is three-Dimensional CT based Conformal Radiotherapy Superior to Two-dimensional X ray-based Radiotherapy for Neoadjuvant Radiotherapy in Locally advanced Carcinoma Rectum? 局部晚期直肠癌新辅助放疗中基于三维CT的适形放疗优于基于二维X线的放疗?
Cancer Therapy & Oncology International Journal Pub Date : 2020-01-24 DOI: 10.19080/CTOIJ.2020.15.555515
Chandana Sanjee
{"title":"Is three-Dimensional CT based Conformal Radiotherapy Superior to Two-dimensional X ray-based Radiotherapy for Neoadjuvant Radiotherapy in Locally advanced Carcinoma Rectum?","authors":"Chandana Sanjee","doi":"10.19080/CTOIJ.2020.15.555515","DOIUrl":"https://doi.org/10.19080/CTOIJ.2020.15.555515","url":null,"abstract":"4.7-Abstract Aim: Estimate deficiency in target volume coverage when using conventional X ray-based planning using bony landmarks in carcinoma rectum. Methods and Material: The study consists of 86 biopsy proven patients of carcinoma rectum. The planned area of treatment was demarcated as per 2D bony landmarks in AP and lateral portals were used following which a 3-field plan was created. This plan was projected on a CT scan in which gross tumour volume, clinical target volume and planning target volume were delineated as per RTOG guidelines, thus comparing 2 dimensional vs. 3 dimensional techniques of treatment. Geographic miss of the nodal target when using conventional technique was estimated in comparison to 3D volume planning on the CT scan. Statistical analysis used: Data were statistically described in terms of mean ± standard deviation, median, and range. Comparison between the study plans was done using Chi square test. P < 0.05 was considered statistically significant. All statistical calculations were done using computer programs SPSS (Statistical Package for the Social Science; SPSS Inc., Chicago, IL, USA) version 15 for Microsoft Windows. Results: When the PTV was superimposed on digital reconstructed radiograph (DRR), 32 out of 86 patients had geographical miss at the superior border, hence missing to cover the internal iliac group of lymph nodes when conventional 2-dimensional techniques were used to delineate target volume. When 2D plan coverage was superimposed on 3D volume DRR, volume receiving 95% of dose was 93% in the 2D plan whereas the coverage of V95 was 98 % (p value 0.01) in 3DCRT plan. The geographic miss of nodal target volume was 1.4cm superiorly. When this missed volume was included into the target and planned, PTV coverage was achieved and small bowel dose was within the planned constraint of V40<30%. Conclusion: CT based planning should be encouraged and in radiation departments where 2-dimensional treatment is practiced, a diagnostic CT scan should be recommended, and the radiation portals should be revised as per the findings of the scan.","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74077962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Poor Outcome and Prolonged Hospital Stay after the Diagnosis of Liver Abscesses in Hospitalized Cancer Patients: A Single Center Experience 肝癌住院患者肝脓肿诊断后预后差和住院时间延长:单中心经验
Cancer Therapy & Oncology International Journal Pub Date : 2020-01-23 DOI: 10.19080/CTOIJ.2020.15.555914
P. K. Shahi
{"title":"Poor Outcome and Prolonged Hospital Stay after the Diagnosis of Liver Abscesses in Hospitalized Cancer Patients: A Single Center Experience","authors":"P. K. Shahi","doi":"10.19080/CTOIJ.2020.15.555914","DOIUrl":"https://doi.org/10.19080/CTOIJ.2020.15.555914","url":null,"abstract":"Background: Liver abscesses are uncommon, but they are associated with a hospital mortality rate of 10% in patients without cancer. However, its relevance in cancer patients in terms of survival and length of hospitalization is unknown. Patients and Methods: We conducted an observational study in order to analyze the impact of liver abscesses in hospitalized cancer patients. Eligible patients were adults with a solid tumor, received antineoplastic treatment and were hospitalized in our department with a diagnosis of liver abscesses. Primary end-points of the study were overall survival (OS) and mean hospital stay (MHS). Secondary end-points were the description of risk factors of liver abscesses, isolated microorganisms and the specific treatment. Results: In our study the incidence of liver abscesses in cancer patients was 1.85%. Median age was 64 years, 60% were men, and the vast majority of patients had an advanced bilio-pancreatic tumor (80%). With a median follow-up of 18 months, median OS was 6 months (95% CI: 1-12); and OS probability at 18-month was 27%. MHS was 30.5 days (95% CI: 20.3-40.7). Risk factors for developing liver abscesses were: a) bilio-pancreatic cancers; b) chemotherapy administration; c) severe malnutrition; and d) biliary drainage/prosthesis. Eight patients (53.3%) had bacteremia, and the most common isolated microorganism was E.coli (33.3%). Percutaneous drainage of abscesses was performed in 53.3% of the patients, and all patients were treated with broad-spectrum antibiotics. Conclusion: Although liver abscesses were uncommon, they were associated with a prolonged hospitalization and poor outcome in cancer patients.","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78775687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update in treatment of Symptomatic newly Diagnosed Transplant Eligible Multiple Myeloma Patients 有症状的新诊断符合移植条件的多发性骨髓瘤患者的治疗进展
Cancer Therapy & Oncology International Journal Pub Date : 2020-01-22 DOI: 10.19080/CTOIJ.2020.15.555913
N. Hamed
{"title":"Update in treatment of Symptomatic newly Diagnosed Transplant Eligible Multiple Myeloma Patients","authors":"N. Hamed","doi":"10.19080/CTOIJ.2020.15.555913","DOIUrl":"https://doi.org/10.19080/CTOIJ.2020.15.555913","url":null,"abstract":"This article tries to answer the following questions i. Is it necessary to incorporate cytogenetic risk categorization in induction decision making?","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80861041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Epidemiological, therapeutic and Evolutionary Profile of Carcinoma 癌症的流行病学、治疗和进化概况
Cancer Therapy & Oncology International Journal Pub Date : 2020-01-21 DOI: 10.19080/ctoij.2020.15.555912
J. H
{"title":"The Epidemiological, therapeutic and Evolutionary Profile of Carcinoma","authors":"J. H","doi":"10.19080/ctoij.2020.15.555912","DOIUrl":"https://doi.org/10.19080/ctoij.2020.15.555912","url":null,"abstract":"","PeriodicalId":9575,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77110232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书